VentriPoint Diagnostics is a Seattle-based provider of a superior heart analysis system. The VentriPoint technology uses conventional 2-dimensional ultrasound data, plus a patented system for analyzing the data called Knowledge-Based Reconstruction (NYSE:KBR). The result is a 3-dimensional model of the heart, providing critical information regarding things like heart volumes and cardiac output.
The VentriPoint system, called Angelo, is of special value for doing what is called right-heart analysis, where the physician needs a clear view of the portion of the heart that pumps blood to the lungs for oxygenation. It is normally difficult to image the right heart using ultrasound, due to the obstruction of the ribs. As a result, physicians often use MRI imaging to get the necessary detail, even though MRI imaging costs more and is more difficult for the patient, especially for children. The VentriPoint system provides the needed heart information without requiring an MRI, but rather with easy-to-use and far less expensive ultrasound technology. It removes the need to sedate children and for second visits.
The VentriPoint system has key applications for congenital heart disease and pulmonary arterial hypertension, and is being researched for a number of other applications:
• Single ventricle
• Perimount (NYSE:R) Valves
• Workflow analysis
• Economic analysis
• RV to PA conduit
• Left ventricle
• Heart failure
• Coronary artery disease
The system has already been installed in major cardiac centers in Canada, Europe, and North America, and has also been the subject of scientific publications in major heart journals.
For more information, visit ventripoint.com